A Post-marketing surveillance study of a combined diphtheria, tetanus, whole-cell pertussis, and hepatitis B vaccine in the Philippines

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 31, Issue 3, 2000, Pages 487-492

  Ducusin, Joyce ^a   Dayrit, Elvira ^a   Simbulan, Aylene ^a   Tuazon, Alexander ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HIB HEPATITIS B VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS-HIB-HEPATITIS B VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE;

ARTICLE; CLINICAL TRIAL; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; PARENT; PHILIPPINES; POSTMARKETING SURVEILLANCE; PSYCHOLOGICAL ASPECT;

DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FOLLOW-UP STUDIES; HAEMOPHILUS VACCINES; HEALTH PERSONNEL; HEPATITIS B VACCINES; HUMANS; INFANT; PARENTS; PHILIPPINES; POPULATION SURVEILLANCE; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 0034278682     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (CDC). Status report on the childhood immunization initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months - United States. 1996. MMWR 1997; 46:657-64.
2. Centers for Disease Control and Prevention (CDC). Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). MMWR 1999; (RR-5): 1-16.
3. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 1855-9.
4. Chiu HH, Huang LM, Lee PI, Safary A, Lee CY. Diphtheria, tetanus and whole cell pertussis vaccine combined with hepatitis B vaccines: a comparison of two doses (10 μg and 5 μg). Pediatr Infect Dis J 1998; 17: 206-11.
5. Choo S, Finn A. Pediatric combination vaccines. Curr Opin Pediatr 1999; 11: 14-20.
6. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 1981; 68: 650-60.
7. Da Villa G, Piccinino F, Scolastico C, Fusco M, Piccinino R, Sepe A. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project. Res Virol 1998; 149: 263-70.
8. Díez-Domingo J, Pereiro Berenguer I, Ferrer Salvà A, et al. The coverage of vaccines systematically administered and of a vaccine against Haemophilus influenzae type b prior to its inclusion in the vaccinal calendar in the Valencian Community. An Esp Pediatr 1998; 49: 568-70.
9. Díez-Delgado J, Dal-Ré R, Llorente M, González A, López J. Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis component of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants. Vaccine 1997; 15: 1418-22.
10. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349-55.
11. Ferson MJ, McKenzie KA, Macartney-Bourne F. Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines. Aust N Z J Public Health 1997; 21: 735-8.
12. Hinman AR. Global progress in infectious disease control. Vaccine 1998; 16: 1116-21.
13. Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998; 28: 930-8.
14. Kew MC, Yu MC, Kedda MA, Coppin A, Sarkin A, Hodkinson J. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997; 112: 184-7.
15. Lee CL, Ko YC. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997; 99: 351-3.
16. Papaevangelou G, Karvelis E, Alexiou D, et al. Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule. Vaccine 1995; 13: 175-8.
17. Poovorawan Y, Theamboonlers A, Sanpavat S, Chumdermpadetsuk S, Safary A, Vandepapeliére P. Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria, tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine in healthy infants. Ann Trop Paediatr 1997; 17: 301-8.
18. Prikazsky V, Vandepapeliére P. Clinical comparison of a combined diphtheria-tetanus-whole-cell pertussis-hepatitis B vaccine with separate administration of DTPw and hepatitis B vaccines in infants. J Paediatr Child Health 1999; 33 (suppl 1): S122
19. Schwabe RF, Stremmel W. The natural course of hepatitis B and hepatitis C virus infection. Schweiz Rundsch Med Prax 1998; 87: 1403-7.
20. Usonis V, Bakasenas V, Taylor D, Vandepapelière P. Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants. Eur J Pediatr 1996; 155: 189-93.
21. Weniger BG, Chen RT, Jacobson SH, et al. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine 1998; 16: 1885-97.
22. World Health Organization (WHO). The children's vaccine initiative and the global programme for vaccines and immunization: recommendations from the special advisory group of experts, Part I. WER 1996; 71: 261-6.
23. World Health Organization (WHO). Imaginative ways of raising immunization coverage. EPI Update 1997; 32: 1-5.
24. st Century - A vision for all. World Health Organization, Geneva, 1998.
25. World Health Organization (WHO). Vaccines and Biologicals Annual Report, 1998. World Health Organization, Geneva, 1999.